Taimur Sher, MBBS, MD

Taimur Sher is a Hematologist/Internist/Oncologist at Mayo Clinicexternal link, opens in a new tab, Jacksonville, Florida and is particularly interested in amyloidosis, plasma cell malignancies, lymphoid malignancies, bone marrow transplant and novel therapeutics and early stage drug development.

Dr. Sher completed Residency in Internal Medicine from Mount Sinai Hospital Medical Center and Fellowship in Hematology and Medical Oncology from Department of Medicine Roswell Park Cancer Institute, State University of New York at Buffalo. He obtained a primary degree in medicine from King Edward Medical College, University of Punjab, Lahore.

Representative Publications:

First Report of Hereditary Lysozyme Amyloidosis in a South Asian Family external link, opens in a new tab

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD-56-positive Multiple Myelomaexternal link, opens in a new tab

Targeting CD38 with daratumumab is lethal to Waldenstrom macroglobulinaemia cellsexternal link, opens in a new tab

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statementexternal link, opens in a new tab